slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 44,971-45,000
Pages 10,126
Rows per page 30
Component
44,971-45,000 of 303,780
23
The slide combines historical financial performance with forward-looking headcount targets and a list of recent M&A transactions.Lazard | Investor Presentation Deck | 46 slides · Lazard
Conference presentation Investor relations 2 hits
27
Lazard | Investor Presentation Deck | 46 slidesLazard | Investor Presentation Deck | 46 slides · Lazard
Conference presentation Investor relations 2 hits
29
The slide uses a combination of grouped bar charts and a line chart to illustrate segment performance and total adjusted operating margin.Lazard | Investor Presentation Deck | 46 slides · Lazard
Conference presentation Investor relations Beat · Financials2 hits
31
The chart shows a debt maturity ladder alongside cash and undrawn revolver availability.Lazard | Investor Presentation Deck | 46 slides · Lazard
Conference presentation Investor relations Beat · Financials2 hits
32
The chart uses a stacked bar format for capital returns and a separate line/box format for net income.Lazard | Investor Presentation Deck | 46 slides · Lazard
Conference presentation Investor relations Beat · Financials2 hits
33
The slide highlights capital allocation strategy via dividends and buybacks.Lazard | Investor Presentation Deck | 46 slides · Lazard
Conference presentation Investor relations Beat · Financials2 hits
36
The slide uses a standard ESG framework to categorize corporate initiatives and business-specific integration strategies.Lazard | Investor Presentation Deck | 46 slides · Lazard
Conference presentation Investor relations 2 hits
01
Lionsgate | SPAC Presentation Deck | 30 slidesLionsgate | SPAC Presentation Deck | 30 slides · Lionsgate
Conference presentation Investment bank 2 hits
07
The slide uses a logo-grid to demonstrate market reach across four key distribution segments.Lionsgate | SPAC Presentation Deck | 30 slides · Lionsgate
Conference presentation Investment bank Beat · SolutionLoop · Cost Of Inaction2 hits
09
The slide uses a comparison frame to demonstrate the consistency and profitability of two distinct business segments.Lionsgate | SPAC Presentation Deck | 30 slides · Lionsgate
Conference presentation Investment bank Loop · Cost Of Inaction2 hits
24
This is a standard financial disclosure slide explaining the methodology behind non-GAAP metrics used in the presentation.Lionsgate | SPAC Presentation Deck | 30 slides · Lionsgate
Conference presentation Investment bank 2 hits
26
Includes detailed footnotes explaining NRE (Not Reasonably Estimated) items.Lionsgate | SPAC Presentation Deck | 30 slides · Lionsgate
Conference presentation Investment bank 2 hits
27
The slide uses 'NRE' (Not Reasonably Estimable) for line items, with a single quantitative data point of $60.0 million for the final Adjusted OIBDA.Lionsgate | SPAC Presentation Deck | 30 slides · Lionsgate
Conference presentation Investment bank 2 hits
28
Includes Safe Harbor Statement and specific footnotes regarding intercompany debt and paydown.Lionsgate | SPAC Presentation Deck | 30 slides · Lionsgate
Conference presentation Investment bank 2 hits
01
LVMH | Results Presentation Deck | 31 slidesLVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Attention2 hits
14
The slide serves as a section divider or speaker introduction.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Loop · Quick Win Big Bet2 hits
16
The chart illustrates the bridge between 2022 and 2023 revenue figures.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Satisfaction2 hits
21
The table includes a row for operating margin percentage and a row for 'Other activities & eliminations'.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Satisfaction2 hits
23
The chart illustrates a bridge from 21,055 M€ in 2022 to 22,802 M€ in 2023.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · ActionLoop · Before After2 hits
01
Mainz Biomed NV | Investor Presentation Deck | 24 slidesMainz Biomed NV | Investor Presentation Deck | 24 slides · Mainz Biomed
Pitch deck Investor relations 2 hits
05
The slide uses a minimalist design with a halftone pattern and company branding.Mainz Biomed NV | Investor Presentation Deck | 24 slides · Mainz Biomed
Pitch deck Investor relations 2 hits
07
The slide outlines the technical workflow from sample collection to diagnostic output.Mainz Biomed NV | Investor Presentation Deck | 24 slides · Mainz Biomed
Pitch deck Investor relations Beat · Solution2 hits
09
The slide features a minimalist design with a corporate logo and a halftone dot pattern.Mainz Biomed NV | Investor Presentation Deck | 24 slides · Mainz Biomed
Pitch deck Investor relations 2 hits
11
The slide uses data from a 2022 JNCI study to justify the clinical importance of AA detection sensitivity.Mainz Biomed NV | Investor Presentation Deck | 24 slides · Mainz Biomed
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
12
The slide highlights the integration of mRNA and DNA biomarkers into a proprietary algorithm for colorectal cancer (CRC) and advanced adenoma (AA) detection.Mainz Biomed NV | Investor Presentation Deck | 24 slides · Mainz Biomed
Pitch deck Investor relations 2 hits
18
Slide 18 of a pitch deck.Mainz Biomed NV | Investor Presentation Deck | 24 slides · Mainz Biomed
Pitch deck Investor relations 2 hits
19
Mainz Biomed NV | Investor Presentation Deck | 24 slidesMainz Biomed NV | Investor Presentation Deck | 24 slides · Mainz Biomed
Pitch deck Investor relations Beat · Team2 hits
01
Matinas BioPharma | Investor Presentation Deck | 29 slidesMatinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations 2 hits
06
Matinas BioPharma | Investor Presentation Deck | 29 slidesMatinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations 2 hits
09
The slide uses a process flow diagram to map clinical outcomes to specific trial metrics.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction2 hits